| Human CT83 (HLA-A*01:01) Protein (LTP10139) |
| LTP10139 |
| 100ug |
|
$406 In stock |
| Cancer/testis antigens 83 (CT83), also called KK-LC-1 or CXorf61, recognized by cytotoxic T lymphocytes (CTL), has become a promising target for immunotherapy. |
| Recombinant Human CT83(HLA-A*01:01) Protein is expressed from Expi293 with His tag and Avi Tag at the C-terminal. It contains Gly25-Thr305(HLA-A*01:01),Ile21-Met119(B2M) and NTDNNLAVY peptide. |
| CT83 (HLA-A*01:01) |
| Human |
| Q5SUL5(HLA-A*01:01)&P61769(B2M)&NTDNNLAVY |
| Gly25-Thr305(HLA-A*01:01),Ile21-Met119(B2M)and NTDNNLAVY peptide |
| The protein has a predicted MW of 50.30 kDa. Due to glycosylation, the protein migrates to 55-65 kDa based on the Tris-Bis PAGE result. |
| 0 |
| C-His-Avi |
| Expi293 |
| > 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC |
| Less than 1EU per ug by the LAL method. |
| Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as a protectant before lyophilization. |
| Reconstituted protein stable at -80 C for 12 months, 4 C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
| Shipped at ambient temperature. |
| Centrifuge tubes before opening. Reconstituting to a concentration of more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water. |
| |